The Conversation (0)
Life Science Big News Roundup: Algernon Selects NP-120 for its Lead Phase 2 Trial; BriaCell Announces Clinical Data as Presented at the 2019 San Antonio Breast Cancer Symposium®
Dec. 13, 2019 10:00AM PST
Life Science Investing News
In case you missed it, here is this week’s life science big news roundup.
In case you missed it, here is this week’s life science big news roundup:
Biotech:
- Algernon Pharmaceuticals Selects NP-120 (Ifenprodil) for its Lead Phase 2 Trial for Idiopathic Pulmonary Fibrosis and Chronic Cough
- BriaCell Announces Clinical Data as Presented at the 2019 San Antonio Breast Cancer Symposium®
To see our previous Life Science Investing Big News Roundups, please click here.